GlaxoSmithKline began the Salmeterol Multi-center Asthma Research Trial, called the SMART study, in 1996. GlaxoSmithKline had agreed with the FDA (Food and Drug Administration) to conduct the study to test the safety of Serevent. The study showed a greater rate of adverse events, including death, in African-American using Serevent than in Caucasians. The FDA analyzed the study results in 2004 and found a statistically significant increase in three events: asthma-related deaths, respiratory-related deaths, and combined asthma-related deaths or life-threatening experiences.

Suffered harm from Serevent? You may have a lawsuit. Click here, for a top rated law firm to evaluate your legal rights.

The drug is now sold with a Serevent warning for asthma-related side effects and is recommended for use only as a second drug to treat asthma when the first drug is insufficient or a heath care provider decides that two drugs are needed. The Serevent Medication Guide states that Serevent should never be the only drug prescribed to treat asthma.

Check out the following articles for more information about Serevent, filing a Serevent lawsuit and finding a Serevent attorney.

• For more information about Serevent, see Drug Overview: Serevent Side Effects and Claims
• For more information about Serevent side effects, see Serevent Side Effects – Asthma-Related Attacks and Death
• To find out more about the FDA warning, see Drug Warning: Serevent Side Effects and Risks
• If you would like to learn more about Serevent lawsuits, see Serevent Lawsuits, Litigation & Lawyers: What You Should Know
• To learn more about Serevent attorneys and how to find one, see Serevent Attorney and Lawyer: How to Hire

Suffered harm from Serevent? You may have a lawsuit. Click here, for a top rated law firm to evaluate your legal rights.